Infection
Presentation
Diagnosis a
Treatment
Chlamydia,
Conjunctivitis:
Culture
Erythromycin 50
congenital b
ocular edema
mg/kg/day in four
PCR-based tests
and discharge
divided doses for
not approved
developing days
14 days or
for chlamydial
to weeks after
azithromycin (20
conjunctivitis
birth; less
mg/kg) for 3 days
or pneumonia
purulent than
Conjunctivitis cannot
CXR;
gonorrheal
be treated with
hyperinflation;
conjunctivitis
topical therapy
infiltrates (no
Pneumonia:
alone
characteristic
afebrile staccato
pattern)
Up to 20% of children
cough in infants
may require
2–19 wks of age
retreatment
Gonorrhea,
neonatal b
Ocular:
Culture
hyperpurulent
conjunctivitis
that can result in
permanent
vision loss
Scalp abscess:
associated with
fetal scalp
monitoring
Disseminated:
arthritis,
bacteremia,
meningitis (see
row below)
Gonorrhea,
Arthritis:
Culture
disseminated
monoarticular
PCR on urine,
Dermatitis:
endocervical or
polymorphic
vaginal swabs,
lesions which
or male
can appear as
urethral swabs
pustules,
Conjunctivitis:
ceftriaxone 50
mg/kg × one
(maximum dose:
125 mg) IM
Arthritis/dermatitis:
ceftriaxone 50
mg/kg/day
(maximum dose: 1
g/day) IV or IM for
7 days
Should also be treated
with erythromycin
for Chlamydia
Arthritis/dermatitis:
• 45 kg: ceftriaxone
50 mg/kg/day
(maximum dose: 1
g/day) IV or IM
daily for 7 days